The Glucagon-Like Peptide-1 Receptor Agonists Liraglutide and Semaglutide Improve Cardiovascular and Renal Outcomes Across Baseline Blood Pressure Categories: Analysis of LEADER and SUSTAIN 6 Meeting Abstract

Industry Collaboration International Collaboration

cited authors

  • Leiter, Lawrence A.; Bain, Stephen; Bhatt, Deepak L.; Buse, John; Mazer, C. David; Pratley, Richard; Lindberg, Soren; Rasmussen, Soren; Vrazic, Hrvoje; Verma, Subodh

authors

Publication Date

  • November 6, 2018

webpage

published in

category

keywords

  • Blood pressure
  • Cardiorenal
  • Cardiovascular disease
  • Cardiovascular disease prevention
  • Diabetes (Type II)

volume

  • 138